Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1244232.RAtklDX8WoW1o8KynKW-ilAj9uHVi_gJD2r5sA2UqNSDY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1244232.RAtklDX8WoW1o8KynKW-ilAj9uHVi_gJD2r5sA2UqNSDY130_assertion type Assertion NP1244232.RAtklDX8WoW1o8KynKW-ilAj9uHVi_gJD2r5sA2UqNSDY130_head.
- NP1244232.RAtklDX8WoW1o8KynKW-ilAj9uHVi_gJD2r5sA2UqNSDY130_assertion description "[Low grade gliomas are increasingly seen to be divided into two groups based on IDH mutation status, with astrocytomas developing through IDH mutation followed by p53 mutation, while poor prognosis low grade gliomas and primary glioblastomas (GBMs) are characterized by EGFR amplification, loss of PTEN, and loss of cyclin-dependent kinase inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1244232.RAtklDX8WoW1o8KynKW-ilAj9uHVi_gJD2r5sA2UqNSDY130_provenance.
- NP1244232.RAtklDX8WoW1o8KynKW-ilAj9uHVi_gJD2r5sA2UqNSDY130_assertion evidence source_evidence_literature NP1244232.RAtklDX8WoW1o8KynKW-ilAj9uHVi_gJD2r5sA2UqNSDY130_provenance.
- NP1244232.RAtklDX8WoW1o8KynKW-ilAj9uHVi_gJD2r5sA2UqNSDY130_assertion SIO_000772 25468223 NP1244232.RAtklDX8WoW1o8KynKW-ilAj9uHVi_gJD2r5sA2UqNSDY130_provenance.
- NP1244232.RAtklDX8WoW1o8KynKW-ilAj9uHVi_gJD2r5sA2UqNSDY130_assertion wasDerivedFrom befree-2016 NP1244232.RAtklDX8WoW1o8KynKW-ilAj9uHVi_gJD2r5sA2UqNSDY130_provenance.
- NP1244232.RAtklDX8WoW1o8KynKW-ilAj9uHVi_gJD2r5sA2UqNSDY130_assertion wasGeneratedBy ECO_0000203 NP1244232.RAtklDX8WoW1o8KynKW-ilAj9uHVi_gJD2r5sA2UqNSDY130_provenance.